{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-27T12:22:56.060548+00:00",
  "news": [
    {
      "title": "Pacer Advisors Inc. Acquires 26,543 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxPZUM5YW9lZ0VkWHFpUUdpSV94c0F0MUZpZjJJUXdoWDNGN3dfcmNsb3QxTThGQVh2UENwY1BudnM0Nkt6dVktc1lZUFA0QWVTMXRnMlh3dDRwakQzbklqLXllcG9rc3hCSENQeXZSUmR5dXZERjcybXFMSlN4NFl6ekZfSU9FbUROakYzWE1IVmctNnpZUl9jUzBZNl91N1h2V0xoNUFTeUxWc1VNS0xxOWliWlVGNFdlR3Q4UVJhMXlyUjMtajU5c3RSLWcyUnJQMG9vQWIwdURXS0ZvdGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPZUM5YW9lZ0VkWHFpUUdpSV94c0F0MUZpZjJJUXdoWDNGN3dfcmNsb3QxTThGQVh2UENwY1BudnM0Nkt6dVktc1lZUFA0QWVTMXRnMlh3dDRwakQzbklqLXllcG9rc3hCSENQeXZSUmR5dXZERjcybXFMSlN4NFl6ekZfSU9FbUROakYzWE1IVmctNnpZUl9jUzBZNl91N1h2V0xoNUFTeUxWc1VNS0xxOWliWlVGNFdlR3Q4UVJhMXlyUjMtajU5c3RSLWcyUnJQMG9vQWIwdURXS0ZvdGc?oc=5\" target=\"_blank\">Pacer Advisors Inc. Acquires 26,543 Shares of Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-27T11:33:41+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOVGg3T21sSVAxajNtcHRZNnVjRUM5QWxxTktzY21kLUNQZzNHeUtSTkZXek9SY0UzYUw2bnk3X2ViUUc1a2hKYXRxaVBIekF6QjN2cWZTUHBndWFvZEpkbWpPNjF6SEZCb3ZfcTBEN29lc1ozNExKX0dZV2o2cGNZMGgxR1dTRWN1cEMwY0pLcmFfYmM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxOVGg3T21sSVAxajNtcHRZNnVjRUM5QWxxTktzY21kLUNQZzNHeUtSTkZXek9SY0UzYUw2bnk3X2ViUUc1a2hKYXRxaVBIekF6QjN2cWZTUHBndWFvZEpkbWpPNjF6SEZCb3ZfcTBEN29lc1ozNExKX0dZV2o2cGNZMGgxR1dTRWN1cEMwY0pLcmFfYmM?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-23T02:06:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Our Science | Video Series - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5\" target=\"_blank\">Our Science | Video Series</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-12-19T13:07:09+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Reassessing Valuation After Positive CASGEVY Pediatric Data and Kidney Drug Breakthrough Status - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPOHU5LXRTc1BoaFEtcmZZYmNJUmpPREQyS1NOU2lJYUx0VTR4UHlhUVZWQ2dtZWxGTFBkaEkyczBLeTBUbkY3aXM3WHFJRHBNVzdCU1UwRG1yWkZKSjRIUjZ0bk4yandVS1gxRVp4anM3dnp2UVJVMUt5Q0xNWmxTVDZhaGg5T0t3YWY5M1VrN2hzaFhVbDI2T2FlZDhiRGZaVG9uNjdyTXNWS0ZCT0JQYXRZOGl0Tm1kaUNPMlJXanpjWEZTb1lKZUs4cDdiUnU0TUpKRWVLN1FpdEQxRUFmMGFIcGZzSUVueEVOV3l4VmZTZ9IB8gFBVV95cUxPOHU5LXRTc1BoaFEtcmZZYmNJUmpPREQyS1NOU2lJYUx0VTR4UHlhUVZWQ2dtZWxGTFBkaEkyczBLeTBUbkY3aXM3WHFJRHBNVzdCU1UwRG1yWkZKSjRIUjZ0bk4yandVS1gxRVp4anM3dnp2UVJVMUt5Q0xNWmxTVDZhaGg5T0t3YWY5M1VrN2hzaFhVbDI2T2FlZDhiRGZaVG9uNjdyTXNWS0ZCT0JQYXRZOGl0Tm1kaUNPMlJXanpjWEZTb1lKZUs4cDdiUnU0TUpKRWVLN1FpdEQxRUFmMGFIcGZzSUVueEVOV3l4VmZTZw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Reassessing Valuation After Positive CASGEVY Pediatric Data and Kidney Drug Breakthrough Status</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-25T04:56:43+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Vertex's gene therapy shows promise in younger children with blood disorders - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5\" target=\"_blank\">Vertex's gene therapy shows promise in younger children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-06T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPY2d6X1piMmhPM010UzdSMndVTVdiSVRBQnpCTkhTZ25hekR1S3I5SDBiVGlkdXJoNk1WbDJNQWRNcEJ2OTRYTkZlTzFxYkxzMTZEVnYxcnpzRGRmZTBtZkgza3NWb1VmbWlSbTIyMHVGWTVjNFJLM21DOENRSWdsX0FZdVRWZUk3S0tLb2FZeEp2ak9nQlJOUw?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-06T08:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQdkNxRlVib3NYOHYzbXY5LUlmNFpCQUlyTUc1b2Y3SE9XWWdXUTBqcEY2clNpOVRnekxsMTROSjZuTHBoLVp1dkh1WEVVLV9HLWZnTWNhN0hUR2xFN3E4NmVtQUVZeUdJUW1VNi0tbzZFVkFpR3RKMFRqZmJjMGZuWHppb00tLUR5?oc=5\" target=\"_blank\">Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2025-12-06T08:00:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-26",
      "close": 462.8999938964844
    },
    "history": [
      {
        "date": "2025-12-17",
        "close": 449.5199890136719
      },
      {
        "date": "2025-12-18",
        "close": 447.3800048828125
      },
      {
        "date": "2025-12-19",
        "close": 456.20001220703125
      },
      {
        "date": "2025-12-22",
        "close": 460.30999755859375
      },
      {
        "date": "2025-12-23",
        "close": 459.2099914550781
      },
      {
        "date": "2025-12-24",
        "close": 462.989990234375
      },
      {
        "date": "2025-12-26",
        "close": 462.8999938964844
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}